Estrogen receptor alpha (ERα) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium

Virchows Archiv

Volumn 453, Issue 6, 2008, Pages 557-569

  Hermon, Tonia L ^a,b   Moore, Alicia B ^a   Yu, Linda ^a   Kissling, Grace E ^a   Castora, Frank J ^b   Dixon, Darlene ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Estrogen receptor alpha phosphorylated serine 118; Phosphorylated mitogen activated protein kinase; Uterine leiomyoma

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOSERINE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UTERUS MYOMA;

ADULT; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; LEIOMYOMA; MENSTRUAL CYCLE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOMETRIUM; PHOSPHORYLATION; PHOSPHOSERINE; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 55849094716     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-008-0679-5     Document Type: Article

References (43)

1. A Barbarisi O Petillo A Di Lieto MA Melone S Margarucci M Cannas G Peluso 2001 17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway J Cell Physiol 186 3 414 424
2. MT Beinfeld JL Bosch KB Isaacson GS Gazelle 2004 Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids Radiology 230 1 207 213
3. V Bourlev S Pavlovitch D Stygar N Volkov B Lindblom M Olovsson 2003 Different proliferative and apoptotic activity in peripheral versus central parts of human uterine leiomyomas Gynecol Obstet Invest 55 4 199 204
4. G Bunone PA Briand RJ Miksicek D Picard 1996 Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation Embo J 15 9 2174 2183
5. VC Buttram Jr 1986 Uterine leiomyomata-aetiology, symptomatology and management Prog Clin Biol Res 225 275 296
6. N Chegini L Kornberg 2003 Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma J Soc Gynecol Investig 10 1 21 26
7. D Chen E Washbrook N Sarwar GJ Bates PE Pace V Thirunuvakkarasu J Taylor RJ Epstein FV Fuller-Pace JM Egly RC Coombes S Ali 2002 Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera Oncogene 21 32 4921 4931
8. K Chwalisz D DeManno R Garg L Larsen C Mattia-Goldberg T Stickler 2004 Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata Semin Reprod Med 22 2 113 119
9. K Chwalisz MC Perez D Demanno C Winkel G Schubert W Elger 2005 Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis Endocr Rev 26 3 423 438
10. JD Cook CL Walker 2004 Treatment strategies for uterine leiomyoma: the role of hormonal modulation Semin Reprod Med 22 2 105 111
11. RR Denton NJ Koszewski AC Notides 1992 Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding J Biol Chem 267 11 7263 7268
12. S Detre G Saclani Jotti M Dowsett 1995 A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas J Clin Pathol 48 9 876 878
13. D Dixon GP Flake AB Moore H He JK Haseman JI Risinger JM Lancaster A Berchuck JC Barrett SJ Robboy 2002 Cell proliferation and apoptosis in human uterine leiomyomas and myometria Virchows Arch 441 1 53 62
14. JO Emembolu 1987 Uterine fibromyomata: presentation and management in northern Nigeria Int J Gynaecol Obstet 25 5 413 416
15. CM Farquhar CA Steiner I Sozen A Arici 2002 Hysterectomy rates in the United States 1990-1997 Obstet Gynecol 99 2 229 234
16. LC Hodges KD Houston DS Hunter R Fuchs-Young Z Zhang RC Wineker CL Walker 2002 Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells Mol Cell Endocrinol 196 1-2 11 20
17. VM Jasonni A La Marca D Santini 2005 Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium Int J Gynaecol Obstet 89 3 297 298
18. S Kato H Endoh Y Masuhiro T Kitamoto S Uchiyama H Sasaki S Masushige Y Gotoh E Nishida H Kawashima D Metzger P Chambon 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 270 5241 1491 1494
19. BS Katzenellenbogen 2000 Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways J Soc Gynecol Investig 7 1 Suppl S33 S37
20. UA Kayisli M Berkkanoglu G Kizilay L Senturk A Arici 2007 Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle Reprod Sci 14 7 678 686
21. MR Kim DW Park JH Lee DS Choi KJ Hwang HS Ryu CK Min 2005 Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells Mol Hum Reprod 11 11 801 808
22. KA Kovacs A Oszter PM Gocze JL Kornyei I Szabo 2001 Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium Mol Hum Reprod 7 11 1085 1091
23. WL Kraus BS Katzenellenbogen 1993 Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists Endocrinology 132 6 2371 2379
24. WL Kraus KE Weis BS Katzenellenbogen 1995 Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors Mol Cell Biol 15 4 1847 1857
25. DA Lannigan 2003 Estrogen receptor phosphorylation Steroids 68 1 1 9
26. EE Marsh SE Bulun 2006 Steroid hormones and leiomyomas Obstet Gynecol Clin North Am 33 1 59 67
27. T Maruo N Ohara H Matsuo Q Xu W Chen R Sitruk-Ware ED Johansson 2007 Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas Contraception 75 6 Suppl S99 103
28. T Maruo N Ohara J Wang H Matsuo 2004 Sex steroidal regulation of uterine leiomyoma growth and apoptosis Hum Reprod Update 10 3 207 220
29. S Matsuzaki M Canis JL Pouly R Botchorishvili PJ Dechelotte G Mage 2007 Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis Hum Reprod 22 1 124 128
30. F Parazzini 2006 Risk factors for clinically diagnosed uterine fibroids in women around menopause Maturitas 55 2 174 179
31. Rein M (1992) Biology of uterine myomas and myometrium in vitro. In: Barbieri RL (ed) Seminars in reproductive endocrinology. Thieme, New York, pp 310-319
32. FM Reis C Lhullier MI Edelweiss PM Spritzer 2005 In vivo assessment of the regulation of transforming growth factor alpha, epidermal growth factor (EGF), and EGF receptor in the human endometrium by medroxyprogesterone acetate J Assist Reprod Genet 22 1 19 24
33. F Sato M Mori M Nishi R Kudo H Miyake 2002 Familial aggregation of uterine myomas in Japanese women J Epidemiol 12 3 249 253
34. Y Shimomura H Matsuo T Samoto T Maruo 1998 Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma J Clin Endocrinol Metab 83 6 2192 2198
35. I Sozen A Arici 2002 Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata Fertil Steril 78 1 1 12
36. EA Stewart AJ Friedman K Peck RA Nowak 1994 Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle J Clin Endocrinol Metab 79 3 900 906
37. CD Swartz CA Afshari L Yu KE Hall D Dixon 2005 Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines Mol Hum Reprod 11 6 441 450
38. AB Vereide T Kaino G Sager M Arnes A Orbo 2006 Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia Gynecol Oncol 101 2 214 223
39. B Vollenhoven 1998 Introduction: the epidemiology of uterine leiomyomas Baillieres Clin Obstet Gynaecol 12 2 169 176
40. J Wang N Ohara Z Wang W Chen A Morikawa H Sasaki DA DeManno K Chwalisz T Maruo 2006 A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells Hum Reprod 21 7 1869 1877
41. T Washburn A Hocutt DL Brautigan KS Korach 1991 Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues Mol Endocrinol 5 2 235 242
42. T Yamada S Nakago O Kurachi J Wang S Takekida H Matsuo T Maruo 2004 Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells Hum Reprod 19 4 815 821
43. R Zaslawski P Surowiak P Dziegiel L Pretnik M Zabel 2001 Analysis of the expression of estrogen and progesterone receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle Med Sci Monit 7 5 908 913